69.97 USD
+0.08 (+0.11%)
At close: Feb 6, 2026
69.87 USD
-0.1 (-0.14%)
After Hours: 2/6/2026, 8:00:01 PM
Taking everything into account, DXCM scores 7 out of 10 in our fundamental rating. DXCM was compared to 186 industry peers in the Health Care Equipment & Supplies industry. DXCM scores excellent points on both the profitability and health parts. This is a solid base for a good stock. DXCM is not overvalued while it is showing excellent growth. This is an interesting combination. These ratings could make DXCM a good candidate for growth and quality investing.
1. Profitability
1.1 Basic Checks
- In the past year DXCM was profitable.
- In the past year DXCM had a positive cash flow from operations.
- Each year in the past 5 years DXCM has been profitable.
- DXCM had a positive operating cash flow in each of the past 5 years.
1.2 Ratios
- With an excellent Return On Assets value of 9.61%, DXCM belongs to the best of the industry, outperforming 93.01% of the companies in the same industry.
- DXCM's Return On Equity of 26.44% is amongst the best of the industry. DXCM outperforms 97.31% of its industry peers.
- DXCM has a Return On Invested Capital of 15.72%. This is amongst the best in the industry. DXCM outperforms 95.70% of its industry peers.
- Measured over the past 3 years, the Average Return On Invested Capital for DXCM is above the industry average of 8.80%.
- The 3 year average ROIC (11.25%) for DXCM is below the current ROIC(15.72%), indicating increased profibility in the last year.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 9.61% | ||
| ROE | 26.44% | ||
| ROIC | 15.72% |
ROA(3y)7.95%
ROA(5y)8.21%
ROE(3y)23.2%
ROE(5y)22.06%
ROIC(3y)11.25%
ROIC(5y)9.23%
1.3 Margins
- The Profit Margin of DXCM (15.96%) is better than 93.01% of its industry peers.
- In the last couple of years the Profit Margin of DXCM has grown nicely.
- DXCM has a Operating Margin of 18.41%. This is amongst the best in the industry. DXCM outperforms 90.32% of its industry peers.
- DXCM's Operating Margin has improved in the last couple of years.
- DXCM's Gross Margin of 60.20% is fine compared to the rest of the industry. DXCM outperforms 61.29% of its industry peers.
- DXCM's Gross Margin has been stable in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 18.41% | ||
| PM (TTM) | 15.96% | ||
| GM | 60.2% |
OM growth 3Y10.52%
OM growth 5Y8.87%
PM growth 3Y17.27%
PM growth 5Y15.84%
GM growth 3Y-3.98%
GM growth 5Y-0.72%
2. Health
2.1 Basic Checks
- DXCM has a Return on Invested Capital (ROIC), which is just above the Cost of Capital (WACC), which means it is creating some value.
- Compared to 1 year ago, DXCM has more shares outstanding
- Compared to 5 years ago, DXCM has more shares outstanding
- DXCM has a better debt/assets ratio than last year.
2.2 Solvency
- DXCM has an Altman-Z score of 5.10. This indicates that DXCM is financially healthy and has little risk of bankruptcy at the moment.
- DXCM's Altman-Z score of 5.10 is fine compared to the rest of the industry. DXCM outperforms 77.42% of its industry peers.
- DXCM has a debt to FCF ratio of 2.36. This is a good value and a sign of high solvency as DXCM would need 2.36 years to pay back of all of its debts.
- DXCM has a Debt to FCF ratio of 2.36. This is amongst the best in the industry. DXCM outperforms 85.48% of its industry peers.
- A Debt/Equity ratio of 0.47 indicates that DXCM is not too dependend on debt financing.
- DXCM's Debt to Equity ratio of 0.47 is in line compared to the rest of the industry. DXCM outperforms 44.09% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.47 | ||
| Debt/FCF | 2.36 | ||
| Altman-Z | 5.1 |
ROIC/WACC1.63
WACC9.65%
2.3 Liquidity
- A Current Ratio of 1.56 indicates that DXCM should not have too much problems paying its short term obligations.
- DXCM has a Current ratio of 1.56. This is in the lower half of the industry: DXCM underperforms 70.97% of its industry peers.
- DXCM has a Quick Ratio of 1.38. This is a normal value and indicates that DXCM is financially healthy and should not expect problems in meeting its short term obligations.
- DXCM has a Quick ratio (1.38) which is comparable to the rest of the industry.
- The current and quick ratio evaluation for DXCM is rather negative, while it does have excellent solvency and profitability. These ratios do not necessarly indicate liquidity issues and need to be evaluated against the specifics of the business.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.56 | ||
| Quick Ratio | 1.38 |
3. Growth
3.1 Past
- DXCM shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 9.41%, which is quite good.
- Measured over the past years, DXCM shows a very strong growth in Earnings Per Share. The EPS has been growing by 29.25% on average per year.
- DXCM shows quite a strong growth in Revenue. In the last year, the Revenue has grown by 14.21%.
- Measured over the past years, DXCM shows a very strong growth in Revenue. The Revenue has been growing by 22.27% on average per year.
EPS 1Y (TTM)9.41%
EPS 3Y35.38%
EPS 5Y29.25%
EPS Q2Q%35.56%
Revenue 1Y (TTM)14.21%
Revenue growth 3Y18.1%
Revenue growth 5Y22.27%
Sales Q2Q%21.64%
3.2 Future
- The Earnings Per Share is expected to grow by 22.05% on average over the next years. This is a very strong growth
- The Revenue is expected to grow by 13.28% on average over the next years. This is quite good.
EPS Next Y27.5%
EPS Next 2Y23.7%
EPS Next 3Y22.67%
EPS Next 5Y22.05%
Revenue Next Year15.45%
Revenue Next 2Y14.12%
Revenue Next 3Y13.7%
Revenue Next 5Y13.28%
3.3 Evolution
- Although the future EPS growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
- Although the future Revenue growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
4. Valuation
4.1 Price/Earnings Ratio
- Based on the Price/Earnings ratio of 37.62, the valuation of DXCM can be described as expensive.
- Compared to the rest of the industry, the Price/Earnings ratio of DXCM indicates a somewhat cheap valuation: DXCM is cheaper than 71.51% of the companies listed in the same industry.
- The average S&P500 Price/Earnings ratio is at 27.93. DXCM is valued slightly more expensive when compared to this.
- A Price/Forward Earnings ratio of 27.71 indicates a quite expensive valuation of DXCM.
- 72.58% of the companies in the same industry are more expensive than DXCM, based on the Price/Forward Earnings ratio.
- Compared to an average S&P500 Price/Forward Earnings ratio of 27.77, DXCM is valued at the same level.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 37.62 | ||
| Fwd PE | 27.71 |
4.2 Price Multiples
- Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of DXCM indicates a somewhat cheap valuation: DXCM is cheaper than 73.12% of the companies listed in the same industry.
- 83.33% of the companies in the same industry are more expensive than DXCM, based on the Price/Free Cash Flow ratio.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 25.7 | ||
| EV/EBITDA | 23.23 |
4.3 Compensation for Growth
- The PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
- The excellent profitability rating of DXCM may justify a higher PE ratio.
- A more expensive valuation may be justified as DXCM's earnings are expected to grow with 22.67% in the coming years.
PEG (NY)1.37
PEG (5Y)1.29
EPS Next 2Y23.7%
EPS Next 3Y22.67%
5. Dividend
5.1 Amount
- No dividends for DXCM!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
69.97
+0.08 (+0.11%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)10-30 2025-10-30/amc
Earnings (Next)02-12 2026-02-12/amc
Inst Owners99.77%
Inst Owner Change-4.27%
Ins Owners0.19%
Ins Owner Change0.62%
Market Cap27.29B
Revenue(TTM)4.52B
Net Income(TTM)720.70M
Analysts85.95
Price Target87.74 (25.4%)
Short Float %3.98%
Short Ratio2.96
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)6.05%
Min EPS beat(2)5.32%
Max EPS beat(2)6.77%
EPS beat(4)2
Avg EPS beat(4)-0.91%
Min EPS beat(4)-11.66%
Max EPS beat(4)6.77%
EPS beat(8)6
Avg EPS beat(8)4.61%
EPS beat(12)10
Avg EPS beat(12)13.69%
EPS beat(16)11
Avg EPS beat(16)6.53%
Revenue beat(2)2
Avg Revenue beat(2)0.74%
Min Revenue beat(2)0.61%
Max Revenue beat(2)0.88%
Revenue beat(4)2
Avg Revenue beat(4)0.02%
Min Revenue beat(4)-1.2%
Max Revenue beat(4)0.88%
Revenue beat(8)2
Avg Revenue beat(8)-0.92%
Revenue beat(12)5
Avg Revenue beat(12)-0.38%
Revenue beat(16)6
Avg Revenue beat(16)-0.58%
PT rev (1m)-0.9%
PT rev (3m)-14.09%
EPS NQ rev (1m)0.41%
EPS NQ rev (3m)0.29%
EPS NY rev (1m)0.16%
EPS NY rev (3m)-0.07%
Revenue NQ rev (1m)0.39%
Revenue NQ rev (3m)0.24%
Revenue NY rev (1m)0.08%
Revenue NY rev (3m)0.04%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 37.62 | ||
| Fwd PE | 27.71 | ||
| P/S | 6.04 | ||
| P/FCF | 25.7 | ||
| P/OCF | 18.85 | ||
| P/B | 10.01 | ||
| P/tB | 10.4 | ||
| EV/EBITDA | 23.23 |
EPS(TTM)1.86
EY2.66%
EPS(NY)2.52
Fwd EY3.61%
FCF(TTM)2.72
FCFY3.89%
OCF(TTM)3.71
OCFY5.31%
SpS11.58
BVpS6.99
TBVpS6.73
PEG (NY)1.37
PEG (5Y)1.29
Graham Number17.1
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 9.61% | ||
| ROE | 26.44% | ||
| ROCE | 19.96% | ||
| ROIC | 15.72% | ||
| ROICexc | 77.75% | ||
| ROICexgc | 88.6% | ||
| OM | 18.41% | ||
| PM (TTM) | 15.96% | ||
| GM | 60.2% | ||
| FCFM | 23.51% |
ROA(3y)7.95%
ROA(5y)8.21%
ROE(3y)23.2%
ROE(5y)22.06%
ROIC(3y)11.25%
ROIC(5y)9.23%
ROICexc(3y)35.45%
ROICexc(5y)29.66%
ROICexgc(3y)40.94%
ROICexgc(5y)33.19%
ROCE(3y)14.28%
ROCE(5y)11.73%
ROICexgc growth 3Y55.18%
ROICexgc growth 5Y18.96%
ROICexc growth 3Y50.14%
ROICexc growth 5Y16.58%
OM growth 3Y10.52%
OM growth 5Y8.87%
PM growth 3Y17.27%
PM growth 5Y15.84%
GM growth 3Y-3.98%
GM growth 5Y-0.72%
F-Score5
Asset Turnover0.6
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.47 | ||
| Debt/FCF | 2.36 | ||
| Debt/EBITDA | 1.2 | ||
| Cap/Depr | 158.02% | ||
| Cap/Sales | 8.55% | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 134.63% | ||
| Profit Quality | 147.34% | ||
| Current Ratio | 1.56 | ||
| Quick Ratio | 1.38 | ||
| Altman-Z | 5.1 |
F-Score5
WACC9.65%
ROIC/WACC1.63
Cap/Depr(3y)175.34%
Cap/Depr(5y)240.83%
Cap/Sales(3y)9.32%
Cap/Sales(5y)10.84%
Profit Quality(3y)97.76%
Profit Quality(5y)73.64%
High Growth Momentum
Growth
EPS 1Y (TTM)9.41%
EPS 3Y35.38%
EPS 5Y29.25%
EPS Q2Q%35.56%
EPS Next Y27.5%
EPS Next 2Y23.7%
EPS Next 3Y22.67%
EPS Next 5Y22.05%
Revenue 1Y (TTM)14.21%
Revenue growth 3Y18.1%
Revenue growth 5Y22.27%
Sales Q2Q%21.64%
Revenue Next Year15.45%
Revenue Next 2Y14.12%
Revenue Next 3Y13.7%
Revenue Next 5Y13.28%
EBIT growth 1Y28.95%
EBIT growth 3Y30.52%
EBIT growth 5Y33.11%
EBIT Next Year73.63%
EBIT Next 3Y36.37%
EBIT Next 5Y30.77%
FCF growth 1Y112.47%
FCF growth 3Y127.88%
FCF growth 5Y36.21%
OCF growth 1Y93.75%
OCF growth 3Y30.77%
OCF growth 5Y25.76%
DEXCOM INC / DXCM FAQ
Can you provide the ChartMill fundamental rating for DEXCOM INC?
ChartMill assigns a fundamental rating of 7 / 10 to DXCM.
Can you provide the valuation status for DEXCOM INC?
ChartMill assigns a valuation rating of 5 / 10 to DEXCOM INC (DXCM). This can be considered as Fairly Valued.
Can you provide the profitability details for DEXCOM INC?
DEXCOM INC (DXCM) has a profitability rating of 9 / 10.
Can you provide the PE and PB ratios for DXCM stock?
The Price/Earnings (PE) ratio for DEXCOM INC (DXCM) is 37.62 and the Price/Book (PB) ratio is 10.01.